Barely Significant
← all excerpts

Evaluation of a Novel Liquid Fiducial Marker, BioXmark<sup>®</sup>, for Small Animal Image-Guided Radiotherapy Applications.

Cancers (Basel) · 2020 · PMC7280978 · PMID 32443537

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

may be significantno p-value reported
These effects may be significant during radiobiological studies and could be minimised by removing BioXmark ® from the point-dose calculation.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.